Dr. John Streicher, Ph.D.
Dr. John Streicher earned his Ph.D. from UCLA in 2009, in the lab of Dr. Yibin Wang, where he studied the signal transduction cascades linking heart stress to heart failure. He then went on to a postdoctoral fellowship with Dr. Laura Bohn at Scripps-Florida, where he studied biased signaling at the opioid receptors. In 2012, he joined the faculty at the University of New England, where he combined the threads of his training into a research program focused on thesignaltransduction cascades of the opioid, cannabinoid, and other brain-relevant receptors, mostly in the context of pain. He joined the faculty of the University of Arizona in 2015, where he continues his work today. Recently, his research program has focused on the effects of terpene compounds found in Cannabis sativa. In a recent paper published in Scientific Reports, his lab found that alpha-humulene, beta-pinene, linalool, and geraniol produced cannabinoid-like effects in mice. This work recently secured funding from the National Institutes of Health to investigate terpenes as potential non-opioid, non-cannabinoid treatments for chronic pain with reduced side effects.